Skip to main content

Table 2 Median plasma levels of sCD163 in mg/L (IQR) at 1: last sample before initiation of ART, 2: three months after ART, 3: one year before case’s MI/index date, and 4: last sample before case’s MI/index date

From: Soluble CD163 does not predict first-time myocardial infarction in patients infected with human immunodeficiency virus: a nested case–control study

 

Sample 1

Sample 2

Sample 3

Sample 4

Cases

3.22

2.87

2.33

2.38

(2.53 – 4.32)

(2.22 – 3.51)

(1.73 – 3.31)

(1.86 – 3.58)

n = 51

n = 49

n = 51

n = 55

Controls

3.03

2.68

2.24

2.24

(2.50 – 4.58)

(2.13 – 3.70)

(1.65 – 2.98)

(1.69 – 2.99)

n = 165

n = 161

n = 172

n = 176

p – valuesa

0.67

0.48

0.66

0.08

  1. a univariate conditional logistic regression.